139 related articles for article (PubMed ID: 38429660)
21. The combination of SHOX2 and RASSF1A DNA methylation had a diagnostic value in pulmonary nodules and early lung cancer.
Xie B; Dong W; He F; Peng F; Zhang H; Wang W
Oncology; 2024 Jan; ():. PubMed ID: 38262380
[TBL] [Abstract][Full Text] [Related]
22. Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.
Schneider KU; Dietrich D; Fleischhacker M; Leschber G; Merk J; Schäper F; Stapert HR; Vossenaar ER; Weickmann S; Liebenberg V; Kneip C; Seegebarth A; Erdogan F; Rappold G; Schmidt B
BMC Cancer; 2011 Mar; 11():102. PubMed ID: 21426551
[TBL] [Abstract][Full Text] [Related]
23. Methylation analysis of SHOX2 and RASSF1A in bronchoalveolar lavage fluid for early lung cancer diagnosis.
Ren M; Wang C; Sheng D; Shi Y; Jin M; Xu S
Ann Diagn Pathol; 2017 Apr; 27():57-61. PubMed ID: 28325362
[No Abstract] [Full Text] [Related]
24. Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging.
Darwiche K; Zarogoulidis P; Baehner K; Welter S; Tetzner R; Wohlschlaeger J; Theegarten D; Nakajima T; Freitag L
Ann Oncol; 2013 Nov; 24(11):2866-70. PubMed ID: 24026539
[TBL] [Abstract][Full Text] [Related]
25. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
[TBL] [Abstract][Full Text] [Related]
26. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive diagnostic scheme of morphological combined molecular methylation under bronchoscopy.
Zhang J; Huang H; Yu F; Bian Y; Wang R; Liu H; Kang S; She B; Shi Z
Front Oncol; 2023; 13():1133675. PubMed ID: 37182143
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.
Dietrich D; Jung M; Puetzer S; Leisse A; Holmes EE; Meller S; Uhl B; Schatz P; Ivascu C; Kristiansen G
PLoS One; 2013; 8(12):e84225. PubMed ID: 24386354
[TBL] [Abstract][Full Text] [Related]
29. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
de Vos L; Gevensleben H; Schröck A; Franzen A; Kristiansen G; Bootz F; Dietrich D
Clin Epigenetics; 2017; 9():125. PubMed ID: 29213339
[TBL] [Abstract][Full Text] [Related]
30. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates.
Schmidt B; Liebenberg V; Dietrich D; Schlegel T; Kneip C; Seegebarth A; Flemming N; Seemann S; Distler J; Lewin J; Tetzner R; Weickmann S; Wille U; Liloglou T; Raji O; Walshaw M; Fleischhacker M; Witt C; Field JK
BMC Cancer; 2010 Nov; 10():600. PubMed ID: 21047392
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
[TBL] [Abstract][Full Text] [Related]
32. Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates.
Dietrich D; Kneip C; Raji O; Liloglou T; Seegebarth A; Schlegel T; Flemming N; Rausch S; Distler J; Fleischhacker M; Schmidt B; Giles T; Walshaw M; Warburton C; Liebenberg V; Field JK
Int J Oncol; 2012 Mar; 40(3):825-32. PubMed ID: 22108652
[TBL] [Abstract][Full Text] [Related]
33. An Internal Control for Evaluating Bisulfite Conversion in the Analysis of Short Stature Homeobox 2 Methylation in Lung Cancer.
Lan VTT; Trang VL; Ngan NT; Son HV; Toan NL
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2435-2443. PubMed ID: 31450918
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta-analysis update.
Zhou X; Lu X; Wu H; Liu J; Huang H
Thorac Cancer; 2021 Dec; 12(24):3327-3332. PubMed ID: 34741433
[TBL] [Abstract][Full Text] [Related]
35. Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis.
Ni S; Ye M; Huang T
Oncotarget; 2017 Sep; 8(37):61253-61263. PubMed ID: 28977861
[TBL] [Abstract][Full Text] [Related]
36. Detection of the DNA methylation of seven genes contribute to the early diagnosis of lung cancer.
Du C; Tan L; Xiao X; Xin B; Xiong H; Zhang Y; Ke Z; Yin J
J Cancer Res Clin Oncol; 2024 Feb; 150(2):77. PubMed ID: 38315228
[TBL] [Abstract][Full Text] [Related]
37. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of Lung Cancer by SHOX2 Gene Methylation Assay.
Song L; Yu H; Li Y
Mol Diagn Ther; 2015 Jun; 19(3):159-67. PubMed ID: 26014676
[TBL] [Abstract][Full Text] [Related]
39. A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer.
Wei B; Wu F; Xing W; Sun H; Yan C; Zhao C; Wang D; Chen X; Chen Y; Li M; Ma J
Sci Rep; 2021 Aug; 11(1):16782. PubMed ID: 34408226
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation of
Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
